Combination treatment with capreomycin of pretreated cavernous pulmonary tuberculosis.
D000284:Administration, Oral; D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002207:Capreomycin / Q000009:adverse effects / Q000627:therapeutic use; D003523:Cycloserine / Q000627:therapeutic use; D004338:Drug Combinations; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000627:therapeutic use; D011859:Radiography; D013828:Thioacetazone / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D004338:Drug Combinations; D002207:Capreomycin; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid